Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuwei Liao

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancer Cell International|June 7, 2021
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)Aisha Al-Dherasi, Qi-Tian Huang, Yuwei Liao, et al.
International Journal of Cancer|March 29, 2019
Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancerJichao Tian, Yan Geng, Dekang Lv, et al.
Cell Research|August 30, 2020
Oncogenic AURKA-enhanced N<sup>6</sup>-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cellsFei Peng, Jie Xu, Bai Cui, et al.
Cancer Medicine|August 2, 2019
Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasmaYuwei Liao, Zhaokui Ma, Yu Zhang, et al.
Cancers|September 5, 2019
High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 StudyMiguel Cordova-Delgado, Mauricio P Pinto, Ignacio N Retamal, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer Cell International|June 7, 2021
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)Aisha Al-Dherasi, Qi-Tian Huang, Yuwei Liao, et al.
International Journal of Cancer|March 29, 2019
Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancerJichao Tian, Yan Geng, Dekang Lv, et al.
Cell Research|August 30, 2020
Oncogenic AURKA-enhanced N<sup>6</sup>-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cellsFei Peng, Jie Xu, Bai Cui, et al.
Cancer Medicine|August 2, 2019
Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasmaYuwei Liao, Zhaokui Ma, Yu Zhang, et al.
Cancers|September 5, 2019
High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 StudyMiguel Cordova-Delgado, Mauricio P Pinto, Ignacio N Retamal, et al.
Pageof 3